A passion for outthinking cancer
Our collaborations

Innovation doesn’t happen alone.
Learn more about teaming with Merrimack.

Learn more

News

View all news
May 30, 2019

Merrimack Pharmaceuticals Announces Completion of Strategic Review, Preservation of Ipsen Milestones and Special Cash Dividend

Read more
May 10, 2019

Merrimack Reports First Quarter 2019 Financial Results

Read more
April 04, 2019

Merrimack Discontinues Development of MM-310

Read more
March 06, 2019

Merrimack Reports Fourth Quarter and Full Year 2018 Financial Results

Read more

Social Media

Follow us on Twitter

October 8, 2018
@MerrimackPharma
We are taking a systematic approach to our preclinical development work. Learn more about our pipeline here: http://wwZRfyJQ2f

October 5, 2018
@MerrimackPharma
Our pipeline is shaped by understanding cancer pathways, treatments designed with pharmacological properties to mat… http://XYlHtTVLHu